What is the equity of Jafron Biomedical Co this year?
Jafron Biomedical Co has equity of 3.15 B CNY this year.
Jafron Biomedical Co Equity 2024
Jafron Biomedical Co Equity
3.15 B CNY
Ticker
300529.SZ
ISIN
CNE100002995
In 2024, Jafron Biomedical Co's equity was 3.15 B CNY, a -11.94% increase from the 3.57 B CNY equity in the previous year.
Jafron Biomedical Co Aktienanalyse
What does Jafron Biomedical Co do?
Jafron Biomedical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Jafron Biomedical Co's Equity
Jafron Biomedical Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Jafron Biomedical Co's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Jafron Biomedical Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Jafron Biomedical Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Jafron Biomedical Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Jafron Biomedical Co stock
What was the equity of Jafron Biomedical Co compared to the previous year?
The equity of Jafron Biomedical Co has increased/decreased by -11.94% decreased compared to the previous year.
What impact does a high equity have on investors of Jafron Biomedical Co?
A high equity is advantageous for investors of Jafron Biomedical Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Jafron Biomedical Co?
A low equity can be a risk for investors of Jafron Biomedical Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Jafron Biomedical Co affect the company?
An increase in equity of Jafron Biomedical Co can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Jafron Biomedical Co affect the company?
A reduction in equity of Jafron Biomedical Co can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Jafron Biomedical Co?
Some factors that can affect the equity of Jafron Biomedical Co include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Jafron Biomedical Co so important for investors?
The equity of Jafron Biomedical Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Jafron Biomedical Co take to change the equity?
To change equity, Jafron Biomedical Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Jafron Biomedical Co pay?
Over the past 12 months, Jafron Biomedical Co paid a dividend of 0.67 CNY . This corresponds to a dividend yield of about 2.5 %. For the coming 12 months, Jafron Biomedical Co is expected to pay a dividend of 0.73 CNY.
What is the dividend yield of Jafron Biomedical Co?
The current dividend yield of Jafron Biomedical Co is 2.5 %.
When does Jafron Biomedical Co pay dividends?
Jafron Biomedical Co pays a quarterly dividend. This is distributed in the months of June, July, June, June.
How secure is the dividend of Jafron Biomedical Co?
Jafron Biomedical Co paid dividends every year for the past 10 years.
What is the dividend of Jafron Biomedical Co?
For the upcoming 12 months, dividends amounting to 0.73 CNY are expected. This corresponds to a dividend yield of 2.72 %.
In which sector is Jafron Biomedical Co located?
Jafron Biomedical Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Jafron Biomedical Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Jafron Biomedical Co from 5/31/2024 amounting to 0.4 CNY, you needed to have the stock in your portfolio before the ex-date on 5/31/2024.
When did Jafron Biomedical Co pay the last dividend?
The last dividend was paid out on 5/31/2024.
What was the dividend of Jafron Biomedical Co in the year 2023?
In the year 2023, Jafron Biomedical Co distributed 0.9 CNY as dividends.
In which currency does Jafron Biomedical Co pay out the dividend?
The dividends of Jafron Biomedical Co are distributed in CNY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Jafron Biomedical Co
Our stock analysis for Jafron Biomedical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Jafron Biomedical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Jafron Biomedical Co Revenue
- Jafron Biomedical Co Net Income
- Jafron Biomedical Co P/E
- Jafron Biomedical Co P/S
- Jafron Biomedical Co EBIT
- Jafron Biomedical Co Dividend
- Jafron Biomedical Co Stocks
- Jafron Biomedical Co Market capitalization
- Jafron Biomedical Co Debt
- Jafron Biomedical Co Liabilities
- Jafron Biomedical Co Equity
- Jafron Biomedical Co AAQS
- Jafron Biomedical Co Employees
- Jafron Biomedical Co ROE
- Jafron Biomedical Co ROA
- Jafron Biomedical Co ROCE